Carlos Lopez-Gaona
Reynosa, TAM 88710, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Nucleolar organization and divergent transcriptional machinery in Giardia lamblia: Structural insights and implications for drug targeting.
Journal: Parasites, hosts and diseases
Published: September 22, 2025
In Silico Investigation of TATA-Binding Protein as a Therapeutic Target for Chagas Disease: Insights into FDA Drug Repositioning.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 20, 2025
TATA-Binding Protein-Based Virtual Screening of FDA Drugs Identified New Anti-Giardiasis Agents.
Journal: International journal of molecular sciences
Published: May 01, 2024
Exploring Genetic Silencing: RNAi and CRISPR-Cas Potential against Drug Resistance in Malaria.
Journal: Mini reviews in medicinal chemistry
Published: January 27, 2024
Analysis of Giardia lamblia Nucleolus as Drug Target: A Review.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 20, 2023
Advances in Protozoan Epigenetic Targets and Their Inhibitors for the Development of New Potential Drugs.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 22, 2023
Advances in the Development of Carbonic Anhydrase Inhibitors as New Antiprotozoal Agents.
Journal: Current medicinal chemistry
Published: February 16, 2023
Ligand-Based Virtual Screening and Molecular Docking of Benzimidazoles as Potential Inhibitors of Triosephosphate Isomerase Identified New Trypanocidal Agents.
Journal: International journal of molecular sciences
Published: June 30, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026